PARIS: A recent research has revealed that people with minor COVID-19 illness can develop antibodies that could leave them immunised for several weeks or more.
According to a French study, people with severe forms of the disease developed antibodies within 15 days of the onset of symptoms.
Researchers stated the results, which have not yet been peer-reviewed, were encouraging since little is known about the mechanisms of immunity against the coronavirus, especially in people with minor forms of the disease.
Arnaud Fontanet, head of the global health department at the Institut Pasteur, which conducted the research with the University Hospital in Strasbourg said, “We now know that this is also true for those who develop minor forms, even if the rates of antibodies are probably weaker.”
The study was carried out on 160 members of staff at two hospital sites in Strasbourg who had all tested positive for COVID-19 and suffered mild forms of the disease. 
The global death toll from the novel coronavirus has crossed the 350,000 marks, according to US-based Johns Hopkins University. Data compiled by the university showed that the number of deaths worldwide has reached 350,423 while 2.28 million people have recovered. 
There are also over 5.58 million confirmed cases worldwide, according to the university, with over 1.68 million recorded so far in the US, making it the country with the most infections.